SCHEMBL3263047

SCHEMBL3263047

Cc1[nH]c2c(F)cc(F)cc2c1CC(N)=O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
KDM4E B2RXH2 3/20 0.39
GAA P10253 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
APOL1 O14791 10/20 0.39
ANO1 Q5XXA6 1/20 0.38
ALDH1A1 P00352 3/20 0.36
LMNA P02545 1/20 0.36
SSTR2 P30874 1/20 0.36
SSTR4 P31391 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GPR84 Q9NQS5 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3261013 0.85 SIRT1 (0.39) MAPTKDM4EGAAMEN1KMT2A
SCHEMBL3379855 0.85 MAP2 (0.47) MAPTKDM4EGAAMEN1KMT2A
SCHEMBL3382173 0.85 SIRT1 (0.38) MAPTKDM4EGAAMEN1KMT2A
SCHEMBL3382968 0.83 ICMT (0.38) MAPTKDM4EGAAMEN1KMT2A
SCHEMBL3264690 0.83 AKR1C2 (0.47) MAPTKDM4EGAAMEN1KMT2A
SCHEMBL3636076 0.81 KDM4E (0.55) MAPTKDM4EGAAMEN1KMT2A
SCHEMBL3261669 0.78 KDM4E (0.44) MAPTKDM4EGAAMEN1KMT2A
SCHEMBL30579451 0.78 SMN1; SMN2 (0.49) MAPTKDM4EKMT2ASSTR2SSTR4
SCHEMBL13496830 0.78 SMN1; SMN2 (0.49) MAPTKDM4EKMT2ASSTR2SSTR4
SCHEMBL22454062 0.77 GPR84 (0.44) MAPTKDM4EAPOL1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010012396-A1 5,6 SUBSTITUTED BENZAMIDE DERIVATIVES AS MODULATORS OF THE EP<SB>2 </SB>RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 WO claimed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP claimed
WO-2010012396-A1 5,6 SUBSTITUTED BENZAMIDE DERIVATIVES AS MODULATORS OF THE EP<SB>2 </SB>RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 WO disclosed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP disclosed